Breaking Barriers in Antibody Drug Discovery!
Our collaboration with Bio-Rad Laboratories has been featured in Manufacturing Chemist!
John Cardone, Marketing Manager at Bio-Rad Laboratories highlights the benefits of combining Salipro Biotech's Salipro® platform with the Bio-Rad PioneerTM platform. Our joint efforts are tackling critical bottlenecks in antibody drug discovery by stabilizing challenging drug targets like GPCRs, ion channels and SLC transporters with Salipro®.
The article showcases how the synergy of these two platforms creates a powerful new approach for antibody discovery, paving the way for next-generation therapeutics targeting previously inaccessible membrane proteins.
The Challenge: Membrane proteins are notoriously difficult to work with, limiting the development of targeted therapies.
The Solution: Salipro's technology stabilizes membrane proteins in their native conformation, preserving their structure and function.
The Breakthrough: Bio-Rad's PioneerTM platform, combined with Salipro's stabilized membrane proteins, enables rapid and efficient generation of high-quality antibodies.
The Impact: This article highlights the successful generation of next-generation antibodies with superior characteristics against CXCR4, a GPCR linked to various cancers.
Together we are unlocking new possibilities for membrane protein targeting therapeutics.
Read the full article to see how the Salipro® and Bio-Rad PioneerTM platforms are making a difference: